myelofibrosis
Showing NaN - NaN of 11
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)
Completed
- Myelofibrosis
- Imetelstat 4.7 mg/kg
- Imetelstat 9.4 mg/kg
-
Birmingham, Alabama
- +71 more
Aug 17, 2021
Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)
Terminated
- Myelofibrosis
-
Stanford, California
- +1 more
Aug 31, 2020
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose
Terminated
- Lymphoma, Large B-Cell, Diffuse
- +20 more
- ASN002 Dose Escalation
- ASN002 RD
-
Tempe, Arizona
- +13 more
Aug 13, 2018
Myelofibrosis Trial in United States (SAR302503 (TG101348))
Completed
- Myelofibrosis
- SAR302503 (TG101348)
-
La Jolla, California
- +5 more
Feb 17, 2016
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Ann Arbor (TAK-901)
Completed
- Acute Myeloid Leukemia
- +11 more
-
Ann Arbor, MichiganUniversity of Michigan
Jul 1, 2013